[Autologous mixed lymphocyte culture (AMLC)]. 1984

H D Volk, and R Grunow

The autologous mixed lymphocyte culture (AMLC) in humans has been reviewed. Normal human T cells are stimulated to proliferate in vitro when co-cultured with mitomycin-C-treated or X-irradiated autologous non-T-cells. This reactivity, termed autologous mixed lymphocyte reaction, is thought to represent a self-recognitive mechanism that might be important in regulating the cellular interactions involved in the generation of normal immune response. The nature of the stimulator cell remains a matter of controversy, with evidence suggesting that monocytes, B cells, or dendritic cells may be the major stimulatory populations. In addition, activated T cells expressing HLA-D/DR antigens are also capable of stimulating autologus T cells in AMLC. It was shown that treatment of stimulator cells with anti-HLA-DR antibodies resulted in a significant decrease in their stimulatory capacity in AMLC. These observations suggest that HLA-D/DR antigens, the human counterpart of murine Ia antigens coded for by the I-E subregion of the H-2 complex, expressed on non-T cells or activated T cells participate in the stimulation of AMLC. However, recent findings would suggest that HLA-DS, the human equivalent of murine I-A, is more important than HLA-DR in inducing proliferation in the AMLC. The nature of the T cell subpopulations stimulated by autologous non-T cells has not been clearly elucidated. Evidence has been presented to suggest that either helper T cells or suppressor T cells, as well as cytotoxic cells may be activated. Recent evidence involving the use of monoclonal antibodies that identify mutually exclusive T cell subsets suggests only T cells with the T4+ (helper/inducer) phenotype are triggered directly, but in the presence of such cells, T8+ (suppressor/cytotoxic) cells may also be activated. The T cells which respond in AMLC are a subset of the Con A-responsive T cell population and are separate from allogeneic MLC-responding T cells. Furthermore, the responding cells are T cells forming rosettes with autologous erythrocytes and have surface and functional characteristic of post-thymic precursors. Recent studies indicate that in AMLC between T and non-T cells or T and activated T cells phenotypically distinct subpopulations of T lymphocytes respond by proliferation and express distinct immunoregulatory function. Thus, it seems that distinct species of Ia antigens expressed on activated T cells as opposed to those expressed on non-T cells could participate in the triggering process for the stimulation of functionally distinct human T cell subpopulations.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

H D Volk, and R Grunow
December 1978, Journal of immunology (Baltimore, Md. : 1950),
H D Volk, and R Grunow
December 1977, The Journal of experimental medicine,
H D Volk, and R Grunow
July 1979, Journal of immunology (Baltimore, Md. : 1950),
H D Volk, and R Grunow
July 2005, Nihon rinsho. Japanese journal of clinical medicine,
H D Volk, and R Grunow
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
H D Volk, and R Grunow
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
H D Volk, and R Grunow
July 1982, Gastroenterology,
H D Volk, and R Grunow
January 1981, Advances in immunology,
Copied contents to your clipboard!